Ligand validation:8OO1

URA: URACIL

URA is a Ligand Of Interest in 8OO1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8OO1_URA_C_504	75%	7%	0.139	0.972	1.72	3.12	2	6	0	0	100%	1
8OO1_URA_A_504	44%	7%	0.207	0.937	1.72	3.11	2	6	0	0	100%	1
3QE7_URA_A_430	73%	7%	0.136	0.965	1.7	3.08	2	6	0	0	100%	1
5XLS_URA_A_501	63%	7%	0.173	0.971	1.73	3.11	2	6	0	0	100%	1
4WPL_URA_A_301	100%	37%	0.052	0.995	1.11	1.36	1	1	0	0	100%	1
5MIW_URA_B_303	100%	3%	0.054	0.996	3.17	2.78	7	3	0	0	100%	1
5LHV_URA_F_303	98%	1%	0.063	0.988	4.64	4.17	8	5	0	0	100%	0.69
2RJ3_URA_A_8001	98%	7%	0.062	0.985	1.6	3.18	2	6	0	0	100%	1
4OEH_URA_E_301	97%	9%	0.063	0.981	1.61	2.88	1	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.